J9118 Injection. calaspargase pegol-mknl
Also known as: calaspargase pegol, Asparlas
Intravenous injection of calaspargase pegol-mknl, a pegylated asparaginase enzyme conjugate.
In Plain Language
amino acid-depleting cancer therapy; leukemia treatment
Clinical Context
Used for acute lymphoblastic leukemia and acute myeloid leukemia, depleting asparagine needed for leukemic cell survival.
RVU Information
CPT J9118 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9118?
CPT J9118 (Injection. calaspargase pegol-mknl) is a J Codes (Drugs) code. Intravenous injection of calaspargase pegol-mknl, a pegylated asparaginase enzyme conjugate.
How is J9118 administered?
CPT J9118 is administered by a healthcare provider, typically via injection or infusion. Used for acute lymphoblastic leukemia and acute myeloid leukemia, depleting asparagine needed for leukemic cell survival. It is used by Hematology/Oncology, Pediatric Oncology.
When is CPT J9118 used?
Used for acute lymphoblastic leukemia and acute myeloid leukemia, depleting asparagine needed for leukemic cell survival.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.